Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On and effective as of July 20, 2022, the Board of Directors of Indaptus Therapeutics, Inc. (the "Company") approved and adopted an amendment (the "First Amendment") to the Company's Amended and Restated Bylaws (the "Bylaws") amending Section 2.8 of Article 2 of the Bylaws to decrease the quorum requirement for stockholder meetings from a majority to 33.3% of the voting power of the capital stock of the Company issued and outstanding, present in person or represented by proxy.

The foregoing summary and description of the provisions of the First Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the First Amendment, a copy of which is filed as Exhibit 3.1 with this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits



Exhibit No.   Description
    3.1         Amendment No. 1 to Amended and Restated Bylaws of Indaptus
              Therapeutics, Inc.
    104       Cover Page Interactive Data File (embedded within the Inline XBRL
              document)

© Edgar Online, source Glimpses